Development of a long-acting direct-acting antiviral system for hepatitis C virus treatment in swine

Development of a long-acting direct-acting antiviral system for hepatitis C virus treatment in swine

Chronic hepatitis C virus (HCV) infection is a leading cause of cirrhosis worldwide and kills more Americans than 59 other infections, including HIV and tuberculosis, combined. While direct-acting antiviral (DAA) treatments are effective, limited uptake of therapy, particularly in high-risk groups,...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид: Verma, Malvika, Chu, Jacqueline N, Salama, John Ashraf Fou, Faiz, Mohammed T., Eweje, Feyisope, Gwynne, Declan A, Lopes, Aaron C, Hess, Kaitlyn, Soares, Vance, Steiger, Christoph Winfried Johannes, McManus, Rebecca S, Koeppen, Ryan P., Hua, Tiffany P, Hayward, Alison M, Collins, Joy E, Tamang, Siddartha M, Ishida, Keiko, Miller, Jonathan B., Katz, Stephanie, Slocum, Alexander H, Sulkowski, Mark S., Thomas, David L., Langer, Robert S, Traverso, Carlo Giovanni
Бусад зохиолчид: Massachusetts Institute of Technology. Department of Biological Engineering
Формат: Өгүүллэг
Хэл сонгох:English
Хэвлэсэн: National Academy of Sciences 2020
Онлайн хандалт:https://hdl.handle.net/1721.1/127652

Интернэт

https://hdl.handle.net/1721.1/127652

Ижил төстэй зүйлс